CAPR
CAPR
NASDAQ · Biotechnology

Capricor Therapeutics Inc

$29.83
+0.23 (+0.78%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +109.3% upside
Low Target $34.96
Average Target $62.44
High Target $82.04
Current Price $29.83
Current
$29.83
Target
$62.44
$34.96 $62.44 avg $82.04
Scenario Analysis
Bear Case
$34.96
17.2%
Low target
Base Case
$62.44
+109.3%
Avg target
Bull Case
$82.04
+175.0%
High target
Risk/Reward
10.2x
Highly favorable
Price in Context
52-Week High
$40.37
-26.1% from high
52-Week Low
$4.30
+593.7% from low
Target vs 52W High
$62.44
+54.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%